Longwen (LWLW) 10-K 14 Jan 15 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Jan. 13, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Dephasium Corp.
Entity Central Index Key	723533
Document Type	10-K
Document Period End Date	31-Dec-13
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2013
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Filer Category	Smaller Reporting Company
Entity Public Float	$451,641
Entity Common Stock, Shares Outstanding		95,164,138

Balance_Sheet

Balance Sheet (USD $)	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS
Cash and cash equivalents	$313	$10,601
TOTAL CURRENT ASSETS	313	10,601
TOTAL ASSETS	313	10,601
CURRENT LIABILITIES
Accrued expenses	516	13,576
Short term loan	9,475	9,475
TOTAL CURRENT LIABILITIES	9,991	23,051
TOTAL LIABILITIES	9,991	23,051
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, no shares issued and outstanding as of December 31, 2013 and 2012, respectively
Common stock, $0.0001 par value, 500,000,000 shares authorized, 45,164,138 and 94,964,138 shares issued and outstanding as of December 31, 2013 and 2012, respectively	4,516	9,496
Common stock to be issued	5,000
Additional paid-in capital	2,617,301	1,388,745
Subscription receivable	-50,000
Accumulated deficit	-2,586,495	-1,410,691
Total Stockholders' (Deficit)	-9,678	-12,450
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)	$313	$10,601

Balance_Sheet_Parenthetical

Balance Sheet (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Balance Sheets [Abstract]
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	45,164,138	94,964,138
Common stock, shares outstanding	45,164,138	94,964,138

Statement_of_Operations

Statement of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Statements of Operations [Abstract]
REVENUES
EXPENSES
General and administrative	45,804	27,450
Impairment loss	1,130,000
Total Expenses	1,175,804	27,450
LOSS FROM CONTINUING OPERATIONS	-1,175,804	-27,450
Loss from discontinued operations		473,823
LOSS BEFORE INCOME TAXES	-1,175,804	-501,273
Provision for income taxes
NET LOSS	($1,175,804)	($501,273)
NET LOSS PER SHARE FROM CONTINUING OPERATIONS - BASIC AND DILUTED	($0.01)	$0
NET LOSS PER SHARE FROM DISCONTINUED OPERATIONS - BASIC AND DILUTED	$0	$0
NET LOSS PER SHARE - BASIC AND DILUTED	($0.01)	$0
WEIGHTED AVERAGE OUTSTANDING SHARES BASIC AND DILUTED	109,226,604	110,173,018

Statements_of_Stockholders_Equ

Statements of Stockholders' Equity (Deficit) (USD $)	Total	Common Stock	Common Stock To Be Issued	Additional Paid-In Capital	Subscription Receivable	Accumulated Deficit
Beginning Balance at Dec. 31, 2011	($324,573)	$12,911		$574,146		($911,630)
Beginning Balance, Shares at Dec. 31, 2011		129,114,138
Recission of share exchange agreement on June 11, 2012	813,396	-3,415		814,599		2,212
Recission of share exchange agreement on June 11, 2012, Shares		-34,150,000
Net Loss	-501,273					-501,273
Ending Balance at Dec. 31, 2012	-12,450	9,496		1,388,745		-1,410,691
Ending Balance, Shares at Dec. 31, 2012		94,964,138
Common stock issued for cash on February 6, 2013	50,000	20		49,980
Common stock issued for cash on February 6, 2013, Shares		200,000
Capital contribution from officer	13,576			13,576
Common stock issued for patent on April 19, 2013	1,200,000	7,000		1,193,000
Common stock issued for patent on April 19, 2013, Shares		70,000,000
Redemption of common stock on April 19, 2013	-15,000	-5,000		-10,000
Redemption of common stock on April 19, 2013, Shares		-50,000,000
Common stock cancelled for returned patent on December 31, 2013	-70,000	-7,000		-63,000
Common stock cancelled for returned patent on December 31, 2013, shares		-70,000,000
Common stock to be issued pursuant to agreement dated December 31, 2013			5,000	45,000	-50,000
Common stock to be issued pursuant to agreement dated December 31, 2013, Shares			50,000,000
Net Loss	-1,175,804					-1,175,804
Ending Balance at Dec. 31, 2013	($9,678)	$4,516	$5,000	$2,617,301	($50,000)	($2,586,495)
Ending Balance, Shares at Dec. 31, 2013		45,164,138	50,000,000

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
OPERATING ACTIVITIES
Net (loss)	($1,175,804)	($501,273)
Net loss from discontinued operations		473,823
Impairment loss	1,130,000
Changes in operating assets and liabilities:
Increase (decrease) in accrued expenses	-13,060	23,052
Net Cash Used by Operating Activities - Continuing Operations	-58,864	-4,398
Net Cash Provided by (used in) Operating Activities - Discontinued Operations		-28,993
NET CASH USED BY OPERATING ACTIVITIES	-58,864	-33,391
FINANCING ACTIVITIES
Proceeds from short term loan		9,475
Proceeds from sale of common stock	50,000
Redemption of common stock	-15,000
Capital contributions from officers	13,576
Net Cash Provided by Financing Activities	48,576	9,475
NET DECREASE IN CASH	-10,288	-23,916
CASH AT BEGINNING OF YEAR	10,601	34,517
CASH AT END OF YEAR	313	10,601
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
Cash paid for taxes
NON-CASH INVESTING ACTIVITY:
Common stock issued for patent acquisition	$1,200,000

Company_Background_and_Organiz

Company Background and Organization	12 Months Ended
	Dec. 31, 2013
Company Background and Organization [Abstract]
COMPANY BACKGROUND AND ORGANIZATION	NOTE 1 – COMPANY BACKGROUND AND ORGANIZATION
	Dephasium Corp., (the Company), was incorporated on March 31, 1980, under the laws of the State of California as Expertelligence, Inc. On June 26, 2006, the Company reincorporated in Nevada. On March 24, 2011, the Company amended its Articles of Incorporation to change its name to Pay Mobile, Inc. On January 2, 2013, the Company amended its Articles of Incorporation to change its name to Allied Ventures Holding Corp. On February 21, 2013, the Company amended its Articles of Incorporation to change its name to Dephasium Corp.
	On March 24, 2011, the Company entered into a Share Exchange Agreement (the Agreement) with Pay Mobile, Inc. (PMD) a Delaware corporation and its shareholders. Pursuant to the terms of the Agreement, the company acquired 100% of the issued and outstanding shares of PMD. On June 11, 2012 the Agreement with PMD was rescinded and the common shares of the Company which were previously issued to the PMD shareholders pursuant to the Agreement were canceled.
	The Company has reverted to a Shell Company status and is looking for a new business opportunity.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
	Fair Value of Financial Instruments
	The Company’s financial instruments consist of cash and cash equivalents and accounts payable and a short-term loan. The carrying amounts of the Company’s financial instruments approximate fair value because of the short term maturity of these items. These fair value estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect those estimates. We do not hold or issue financial instruments for trading purposes, nor do we utilize derivative instruments.
	Intangible Assets
	In accordance with ASC 350-30, which provides guidance on accounting for general intangibles other than goodwill, the Company tests its intangible assets for impairment based on the assets classification as finite-lived or indefinite-lived. The Company’s sole intangible asset was a patent which is deemed to be finite-lived. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If the Company determines that the sum of the undiscounted cash flows expected from the asset’s use and eventual disposal is less than the carrying amount of the asset, an impairment charge is recorded to the extent that the carrying amount exceeds the asset’s fair value. The Company experienced an impairment loss discussed in Note 3.
	Income Taxes
	The Company utilizes the asset and liability method to account for income taxes pursuant to ASC 740 “Income Taxes”. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is used to reduce net deferred tax assets to the amount that, based on management’s estimate, is more likely than not to be realized.
	ASC 740 provides guidance for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. If the Company determines that an uncertain tax position exists in which the Company could incur income taxes, the Company would evaluate whether there is a probability that the uncertain tax position taken would be sustained upon examination by the taxing authorities. A liability for uncertain tax positions would then be recorded if the Company determined it is more likely than not that a position would not be sustained upon examination or if a payment would have to be made to a taxing authority and the amount is reasonably estimable. The Company does not believe any uncertain tax positions exist that would result in the Company having a liability to the taxing authorities. The Company classifies interest and penalties related to unrecognized tax benefits, if and when required, as part of interest expense and other expense in the consolidated statements of operations.
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Stock Based Compensation
	Stock based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.
	Basic Income (Loss) Per Share
	Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common stock by the weighted average number of shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There is no dilutive debt or equity.
	Fair Value Measurements
	The Company follows the provisions of ASC 820, “Fair Value Measurements And Disclosures”. ASC 820 defines fair value, establishes a framework for measuring fair value under generally accepted principles, and enhances disclosures about fair value measurements.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value:
	Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.
	Level 2 – Valuations based on observable inputs other than quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
	Level 3 – Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
	As of December 31, 2013 and 2012, the Company did not have any assets or liabilities that were required to be measured at fair value on a recurring basis or on a non-recurring basis.
	Recent Accounting Pronouncements
	In July 2013, FASB issued guidance regarding the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. Under certain circumstances, unrecognized tax benefits should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. This guidance is effective for fiscal years beginning after December 31, 2013 on either a prospective or retrospective basis. The Company does not believe the adoption of this accounting pronouncement will have a material impact on its financial statements.
	On June 10, 2014 the FASB issued ASU 2014-10, Development Stage Entities, (Topic 915), which eliminates the concept of a development stage entity (DSE) in its entirety from current accounting guidance. The removal of the DSE reporting requirements are effective for public entities for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption of the new standard is permitted and it was adopted by the Company in the quarter ended December 31, 2013.
	The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its financial position, results of operations or cash flows.

Asset_Purchase_and_Restructuri

Asset Purchase and Restructuring Agreements and Impariment Loss	12 Months Ended
	Dec. 31, 2013
Asset Purchase and Restructuring Agreements and Impariment Loss [Abstract]
Asset Purchase and Restrurcturing Agreements and Impairment Loss	NOTE 3 – ASSET PURCHASE AND RESTRUCTURING AGREEMENTS AND IMPAIRMENT LOSS
	On March 5, 2013 the Company entered into an Asset Purchase Agreement for the purchase of a patent from Dephasium, LTD, a limited partnership organized under the laws of the United Kingdom. Pursuant to the Agreement, in consideration of the transfer to the Company of the ANCILIA Patent and Trademark, the Company agreed to issue Dephasium, LTD 70,000,000 shares of its restricted common stock.  As of April 18, 2013, all conditions precedent to the closing were satisfied. The patent was valued and recorded at $1,200,000 based on an independent appraisal.
	Effective December 31, 2013, the Company entered into a “Restructuring Agreement” with Dephasium, LTD whereby (1) the Company shall transfer the patent and Ancilia trademark back to Dephasium, LTD (2) Dephasium LTD shall return the 70,000,000 restricted common stock shares to the Company and said shares are deemed cancelled (3) the Company shall enter into a license agreement for the sale of Dephasium, LTD products and commit up to $25,000 to be used for marketing the products in the United States.
	On December 31, 2013 the value of the Company’s common stock was $0.01 per share. Accordingly, the 70,000,000 returned common shares had a value of $70,000 resulting in an impairment loss on the returned patent and trademark of $1,130,000.

ShortTerm_Loan

Short-Term Loan	12 Months Ended
	Dec. 31, 2013
Short-Term Loan [Abstract]
SHORT-TERM LOAN	NOTE 4 – SHORT-TERM LOAN
	On December 17, 2012 the Company entered into a $9,475 promissory note obligating the Company to repay the loan one year from the date thereof. The annual interest rate is “US Prime” plus 8%. The prime rate on the note’s execution date was 3.25%; accordingly, the annual interest rate is 11.25%. The note matured in December 2013 and the Company did not pay any of the principal. The Company is in default but has not received notification thereof from the lender as required in the note.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2013
Stockholders Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 5 – STOCKHOLDERS’ EQUITY
	Pursuant to the June 11, 2012 rescission of the Share Exchange Agreement referred to in Note 1, the net amount of common shares cancelled by the Company totaled 34,150,000.
	On February 6, 2013 the Company issued 200,000 common shares for proceeds of $50,000.
	On April 19, 2013 the Company redeemed 50,000,000 common shares for $15,000.
	On April 19, 2013 the Company issued 70,000,000 restricted common shares pursuant to the asset purchase agreement referred to in Note 3. The 70,000,000 shares were canceled effective December 31, 2013 pursuant to the restructuring agreement referred to in Note 3.
	Effective December 31, 2013 the Company entered into an agreement to issue 50,000,000 common shares in exchange for $50,000. The Company recorded a subscription receivable for said amount as the $50,000 was received in 2014.
	In 2013 an officer of the Company contributed $13,576.

Commitment

Commitment	12 Months Ended
	Dec. 31, 2013
Commitment [Abstract]
COMMITMENT	NOTE 6 – COMMITMENT
	Pursuant to the restructuring agreement referred to in Note 3, the Company entered into a license for the sale of products. The Company agreed to commit up to $25,000 to be used for marketing the products in the United States.

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2013
Going Concern [Abstract]
Going Concern	NOTE 7 – GOING CONCERN
	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  The Company’s’ financial position and operating results raise substantial doubt about the Company’s ability to continue as a going concern, as reflected by the Company’s accumulated deficit of $2,586,495 and Stockholders’ Deficit of $9,678 at December 31, 2013. In addition, the Company has not generated any revenues since inception. The ability of the Company to continue as a going concern is dependent upon finding a new business opportunity and obtaining additional capital and financing.  The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]
INCOME TAXES	NOTE 8 – INCOME TAXES
	The reconciliation of the federal statutory income tax rate of 34% to the Company’s effective income tax rate is as follows:
		2012			2013
	Income tax benefit using U.S. statutory rate		34	%		34	%
	Valuation allowance		(34.0	)		(34.0	%)
	Effective income tax rate		0	%		0	%
	The components of the Company’s deferred tax asset are as follows as of December 31, 2013 and 2012:
		December 31, 2013			December 31, 2012
	Deferred Tax Asset:
	Net Operating Loss Carryforward	$	285,694		$	270,120
	Valuation Allowance		(285,694	)		(270,120	)
	Total Net Deferred Tax Asset	$	-		$	-
	Change in Valuation Allowance	$	15,574		$	9,333
	The potential deferred tax asset is computed utilizing a 34% federal statutory tax rate. No deferred tax asset has been reported in the financial statements because the Company believes it is more likely than not that the net operating loss (NOL) carryforwards will not be realized. Accordingly, the potential tax benefits of the NOL carryforwards are offset by a valuation allowance of the same amount.
	The increase in the 2013 and 2012 valuation allowance of $15,574 and $9,333, respectively, is solely attributable to deferred tax assets arising from the tax benefit of the NOL carryforward.
	As of December 31, 2013 and December 31, 2012, the Company had NOL carryforwards for income tax reporting purposes of approximately $840,276 and $794,472, respectively; which expire between 2014 and 2033.
	The Company has not filed 2012 and 2013 income tax returns. The Company’s tax returns are subject to examination by the federal tax authorities for years 2011 through 2013.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 – SUBSEQUENT EVENTS
	The Company has evaluated subsequent events through the date the financial statements were available to be issued. Management has determined that no events occurred subsequent to December 31, 2013 that would require disclosure in the financial statements except for the item disclosed in the following paragraph.
	The Company issued 50,000,000 shares of common stock in exchange for the receipt of $50,000 pursuant to the December 31, 2013 agreement referred to in Note 4.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The Company’s financial instruments consist of cash and cash equivalents and accounts payable and a short-term loan. The carrying amounts of the Company’s financial instruments approximate fair value because of the short term maturity of these items. These fair value estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect those estimates. We do not hold or issue financial instruments for trading purposes, nor do we utilize derivative instruments.
Intangible Assets	Intangible Assets
	In accordance with ASC 350-30, which provides guidance on accounting for general intangibles other than goodwill, the Company tests its intangible assets for impairment based on the assets classification as finite-lived or indefinite-lived. The Company’s sole intangible asset was a patent which is deemed to be finite-lived. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If the Company determines that the sum of the undiscounted cash flows expected from the asset’s use and eventual disposal is less than the carrying amount of the asset, an impairment charge is recorded to the extent that the carrying amount exceeds the asset’s fair value. The Company experienced an impairment loss discussed in Note 3.
Income Taxes	Income Taxes
	The Company utilizes the asset and liability method to account for income taxes pursuant to ASC 740 “Income Taxes”. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is used to reduce net deferred tax assets to the amount that, based on management’s estimate, is more likely than not to be realized.
	ASC 740 provides guidance for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. If the Company determines that an uncertain tax position exists in which the Company could incur income taxes, the Company would evaluate whether there is a probability that the uncertain tax position taken would be sustained upon examination by the taxing authorities. A liability for uncertain tax positions would then be recorded if the Company determined it is more likely than not that a position would not be sustained upon examination or if a payment would have to be made to a taxing authority and the amount is reasonably estimable. The Company does not believe any uncertain tax positions exist that would result in the Company having a liability to the taxing authorities. The Company classifies interest and penalties related to unrecognized tax benefits, if and when required, as part of interest expense and other expense in the consolidated statements of operations.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Stock Based Compensation	Stock Based Compensation
	Stock based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.
Basic Income (Loss) Per Share	Basic Income (Loss) Per Share
	Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common stock by the weighted average number of shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There is no dilutive debt or equity.
Fair Value Measurements	Fair Value Measurements
	The Company follows the provisions of ASC 820, “Fair Value Measurements And Disclosures”. ASC 820 defines fair value, establishes a framework for measuring fair value under generally accepted principles, and enhances disclosures about fair value measurements.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value:
	Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.
	Level 2 – Valuations based on observable inputs other than quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
	Level 3 – Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
	As of December 31, 2013 and 2012, the Company did not have any assets or liabilities that were required to be measured at fair value on a recurring basis or on a non-recurring basis.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	In July 2013, FASB issued guidance regarding the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. Under certain circumstances, unrecognized tax benefits should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. This guidance is effective for fiscal years beginning after December 31, 2013 on either a prospective or retrospective basis. The Company does not believe the adoption of this accounting pronouncement will have a material impact on its financial statements.
	On June 10, 2014 the FASB issued ASU 2014-10, Development Stage Entities, (Topic 915), which eliminates the concept of a development stage entity (DSE) in its entirety from current accounting guidance. The removal of the DSE reporting requirements are effective for public entities for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption of the new standard is permitted and it was adopted by the Company in the quarter ended December 31, 2013.
	The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its financial position, results of operations or cash flows.

Income_Tax_Tables

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]
Summrary of reconciliation of the federal statutory income tax rate of 34% to the Company's effective income tax rate		2012			2013
	Income tax benefit using U.S. statutory rate		34	%		34	%
	Valuation allowance		(34.0	)		(34.0	%)
	Effective income tax rate		0	%		0	%
Components of deferred tax asset		December 31, 2013			December 31, 2012
	Deferred Tax Asset:
	Net Operating Loss Carryforward	$	285,694		$	270,120
	Valuation Allowance		(285,694	)		(270,120	)
	Total Net Deferred Tax Asset	$	-		$	-
	Change in Valuation Allowance	$	15,574		$	9,333

Company_Background_and_Organiz1

Company Background and Organization (Details)	Dec. 31, 2013
Company Background and Organization (Texual)
Percentage of issued and outstanding shares acquired	100.00%

Asset_Purchase_and_Restructuri1

Asset Purchase and Restructuring Agreements and Impariment Loss (Details) (USD $)	1 Months Ended	12 Months Ended
	Mar. 05, 2013	Dec. 31, 2013	Dec. 31, 2012	Apr. 18, 2013
Restructuring Cost and Reserve [Line Items]
Restricted common stock issued	70,000,000
Marketing expense		$25,000
Common stock, value per share		$0.01
Restricted shares cancelled, shares		70,000,000
Restricted shares cancelled, value		70,000
Impairment loss on returned patent and trademark		1,130,000
Patents [Member]
Restructuring Cost and Reserve [Line Items]
Patent value				$1,200,000

ShortTerm_Loan_Details

Short-Term Loan (Details) (USD $)	0 Months Ended
	Dec. 17, 2012
Short Term Loan (Textual)
Promissory note, amount	$9,475
Interest rate terms	The annual interest rate is "US Prime" plus 8%. The prime rate on the note's execution date was 3.25%; accordingly.
Annual interest rate	11.25%
Debt instrument maturity date	31-Dec-13

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	1 Months Ended	0 Months Ended	12 Months Ended
	Apr. 19, 2013	Jan. 11, 2012	Dec. 31, 2013	Feb. 06, 2013	Dec. 31, 2012	Dec. 31, 2014
Stockholders Equity (Textual)
Common shares cancelled, value	$15,000	$34,150,000	($15,000)
Common stock, shares issued			45,164,138	200,000	94,964,138
Common Stock, value issued			4,516	50,000	9,496
Common cancelled, shares	50,000,000
Restricted common shares issued	70,000,000
Restricted shares cancelled			70,000,000
Stock issued during period value new issues			50,000
Stock issued during period shares new issues			50,000,000
Employee contribution to share-based compensation			13,576
Subsequent Event [Member]
Stockholders Equity (Textual)
Subscriptions receivable						$50,000

Commitment_Detail

Commitment (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Commitment (Texual)
Marketing expense	$25,000

Going_Concern_Details

Going Concern (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Going Concern (Textual)
Accumulated deficit	($2,586,495)	($1,410,691)
Stockholders' deficit	($9,678)	($12,450)	($324,573)

Income_Tax_Details

Income Tax (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Statutory U.S. Federal income tax rate and the effective rate
Income tax benefit using U.S. statutory rate	34.00%	34.00%
Valuation allowance	-34.00%	-34.00%
Effective income tax rate	0.00%	0.00%

Income_Tax_Details_1

Income Tax (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred Tax Asset:
Net Operating Loss Carryforward	$285,694	$270,120
Valuation Allowance	-285,694	-270,120
Total Net Deferred Tax Asset
Change in Valuation Allowance	$15,574	$9,333

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax (Texual)
Reconciliation of the federal statutory income tax rate	34.00%	34.00%
Potential deferred tax asset computed to federal statutory tax rate	34.00%
Increase in valuation allowance	$15,574	$9,333
NOL carryforwards for income tax	$840,276	$794,472
Operating loss carryforwards expire date	Expire between 2014 and 2033.

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Subsequent Events (Textual)
Proceed from issuance of stock	$50,000
Common stock shares issued	50,000,000